Lexeo’s legal counsel from Cooley, led by partners Eric Blanchard, Div Gupta, Peter Byrne, and associate Dayne Brown, have provided the legal scaffolding for this thrilling ascent. On the other side, Paul Hastings has taken the reins, led by partners Seo Salimi and William Magioncalda, orchestrating the underwriters’ journey to success.
In the world of genetic medicine, Lexeo Therapeutics Inc. is a name to remember, and with their IPO orchestrated by Paul Hastings, the financial landscape is about to witness a tectonic shift. Stay tuned for the next electrifying chapter in this mesmerizing financial odyssey.
